Bio Rad Laboratories Stock Price Prediction

BIO Stock  USD 332.91  7.33  2.25%   
The relative strength index (RSI) of Bio Rad's the stock price is about 61 suggesting that the stock is rather overbought by investors as of today. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Bio, making its price go up or down.

Oversold Vs Overbought

61

 
Oversold
 
Overbought
The successful prediction of Bio Rad's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Bio Rad Laboratories, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Bio Rad's stock price prediction:
Quarterly Earnings Growth
5.412
EPS Estimate Next Quarter
2.76
EPS Estimate Current Year
10.052
EPS Estimate Next Year
11.4719
Wall Street Target Price
402.3333
Using Bio Rad hype-based prediction, you can estimate the value of Bio Rad Laboratories from the perspective of Bio Rad response to recently generated media hype and the effects of current headlines on its competitors.

Bio Rad Laboratories Hype to Price Pattern

Investor biases related to Bio Rad's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Rad Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Bio Rad's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Bio Rad.
The fear of missing out, i.e., FOMO, can cause potential investors in Bio Rad to buy its stock at a price that has no basis in reality. In that case, they are not buying Bio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Bio Rad after-hype prediction price

    
  USD 334.25  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Bio Rad Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
299.62423.26425.60
Details
Naive
Forecast
LowNextHigh
296.69299.04301.38
Details
6 Analysts
Consensus
LowTargetHigh
476.48523.60581.20
Details
Earnings
Estimates (0)
LowProjected EPSHigh
2.222.512.60
Details

Bio Rad After-Hype Price Prediction Density Analysis

As far as predicting the price of Bio Rad at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bio Rad or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bio Rad, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Bio Rad Estimiated After-Hype Price Volatility

In the context of predicting Bio Rad's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bio Rad's historical news coverage. Bio Rad's after-hype downside and upside margins for the prediction period are 331.91 and 336.59, respectively. We have considered Bio Rad's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
332.91
331.91
Downside
334.25
After-hype Price
336.59
Upside
Bio Rad is very steady at this time. Analysis and calculation of next after-hype price of Bio Rad Laboratories is based on 3 months time horizon.

Bio Rad Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Bio Rad is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bio Rad backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bio Rad, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.09 
2.35
  1.00 
  0.12 
10 Events / Month
13 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
332.91
334.25
0.40 
21.10  
Notes

Bio Rad Hype Timeline

On the 25th of November Bio Rad Laboratories is traded for 332.91. The entity has historical hype elasticity of 1.0, and average elasticity to hype of competition of -0.12. Bio is forecasted to increase in value after the next headline, with the price projected to jump to 334.25 or above. The average volatility of media hype impact on the company the price is about 21.1%. The price boost on the next news is projected to be 0.4%, whereas the daily expected return is currently at 0.09%. The volatility of related hype on Bio Rad is about 176.69%, with the expected price after the next announcement by competition of 332.79. The company reported the last year's revenue of 2.67 B. Reported Net Loss for the year was (637.32 M) with profit before taxes, overhead, and interest of 1.57 B. Considering the 90-day investment horizon the next forecasted press release will be in about 10 days.
Check out Bio Rad Basic Forecasting Models to cross-verify your projections.

Bio Rad Related Hype Analysis

Having access to credible news sources related to Bio Rad's direct competition is more important than ever and may enhance your ability to predict Bio Rad's future price movements. Getting to know how Bio Rad's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bio Rad may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
TNDMTandem Diabetes Care 0.72 8 per month 0.00 (0.18) 4.47 (4.60) 13.13 
DXCMDexCom Inc 1.96 9 per month 1.57 (0.05) 4.07 (2.44) 8.17 
INSPInspire Medical Systems(9.85)11 per month 2.62 (0.02) 4.95 (5.08) 16.85 
SWAVShockwave Medical 0.00 0 per month 2.04 (0.03) 3.76 (3.16) 16.22 
PENPenumbra 3.38 9 per month 1.94  0.09  4.63 (2.90) 12.89 
CNMDCONMED(0.47)10 per month 2.27  0.02  4.57 (3.83) 11.47 
BRKRBruker(2.82)9 per month 0.00 (0.1) 4.74 (3.68) 10.80 
ZBHZimmer Biomet Holdings(2.43)10 per month 0.00 (0.09) 1.66 (1.83) 10.18 
GKOSGlaukos Corp 2.86 8 per month 1.66  0.02  3.30 (2.86) 13.23 
NARIInari Medical 0.21 9 per month 2.19  0.02  6.30 (3.87) 19.78 
PODDInsulet(0.59)10 per month 0.64  0.21  3.36 (1.72) 12.33 
GMEDGlobus Medical(0.69)11 per month 0.75  0.11  1.82 (1.59) 11.18 
NVCRNovocure(1.33)10 per month 4.44  0.01  8.08 (6.48) 23.45 
STESTERIS plc(9.53)10 per month 0.00 (0.20) 1.71 (2.09) 8.04 
ANIKAnika Therapeutics 0.16 9 per month 0.00 (0.14) 3.23 (2.96) 34.28 
ITGRInteger Holdings Corp(2.86)9 per month 1.44  0.03  2.48 (2.16) 7.64 

Bio Rad Additional Predictive Modules

Most predictive techniques to examine Bio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bio using various technical indicators. When you analyze Bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Bio Rad Predictive Indicators

The successful prediction of Bio Rad stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bio Rad Laboratories, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bio Rad based on analysis of Bio Rad hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bio Rad's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bio Rad's related companies.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding52.964.4366.8287.31
PTB Ratio1.651.31.082.15

Story Coverage note for Bio Rad

The number of cover stories for Bio Rad depends on current market conditions and Bio Rad's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bio Rad is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bio Rad's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Bio Rad Short Properties

Bio Rad's future price predictability will typically decrease when Bio Rad's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bio Rad Laboratories often depends not only on the future outlook of the potential Bio Rad's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bio Rad's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding29.2 M
Cash And Short Term Investments1.6 B
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out Bio Rad Basic Forecasting Models to cross-verify your projections.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.412
Earnings Share
(28.06)
Revenue Per Share
90.815
Quarterly Revenue Growth
0.028
Return On Assets
0.0186
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.